
Currently out of the existing stock ratings of Gavin Clark-Gartner, 80 are a BUY (95.24%), 4 are a HOLD (4.76%).
Analyst Gavin Clark-Gartner, currently employed at EVERCORE, has had 42.45% of price targets met with an average potential upside of 74.57%, reached in 92 days on average.
Gavin Clark-Gartner has documented 167 price targets and ratings displayed on 24 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ARGX, argenx NV ADR at 22-Oct-2026.
Analyst best performing recommendations are on LBPH (LONGBOARD PHARMACEUTICALS).
The best stock recommendation documented was for LBPH (LONGBOARD PHARMACEUTICALS) on 12/22/2023. The price target of $25 was fulfilled within 11 days with a profit of $19 (316.67%), with a performance score of 287.88.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Feb-2026
$335
$39.97 (13.55%)
$325
4 days ago
(15-Nov-2026)
Buy Since 17-Nov-2020
$338
$42.97 (14.56%)
$282
18 days ago
(01-Nov-2026)
20/21 (95.24%)
$43.11 (14.62%)
335
Buy Since 07-Dec-2021
$340
$44.97 (15.24%)
$300
18 days ago
(01-Nov-2026)
11/13 (84.62%)
$45.11 (15.30%)
479
Buy Since 05-Apr-2022
$346
$50.97 (17.28%)
$310
18 days ago
(01-Nov-2026)
33/35 (94.29%)
$51.11 (17.33%)
486
Buy Since 15-Nov-2023
$325
$29.97 (10.16%)
$290
18 days ago
(01-Nov-2026)
32/33 (96.97%)
$30.11 (10.21%)
244
Which stock is Gavin Clark-Gartner most bullish on?
Which stock is Gavin Clark-Gartner most reserved on?
What Year was the first public recommendation made by Gavin Clark-Gartner?